You are here: Industry Insights > COVID-19

News List

Optimism over global economic recovery hits a low as May ends: Poll analysis pharmaceutical-technology
June 05, 2020
The global economic growth in 2020 has been eclipsed since the COVID-19 pandemic outbreak causing fears of looming unemployment and recession in a number of countries.
Memo Therapeutics discovers neutralising antibodies against Covid-19 pharmaceutical-technology
June 05, 2020
?Switzerland-based Memo Therapeutics has discovered multiple SARS-CoV-2 neutralising antibodies with the potential for development as immunotherapy against Covid-19.
Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi expresspharma
June 05, 2020
Funding secured for Gavi’s next strategic period will help the Alliance reach an additional 300 million children in the world’s most vulnerable communities and save up to eight million lives.
Dalmia Healthcare starts clinical trial of Astha-15 as COVID-19 treatment expresspharma
June 05, 2020
The company declared that set regulatory guidelines of Informed Consent Declaration, Insurance Terms and EC approvals will be followed to conduct the Multi-centric, Phase III clinical trials.
Gavi to award $75 million to Serum Institute of India for introduction of the pneumonia vaccine in d expresspharma
June 05, 2020
Until now, the only two producers of the pneumonia vaccine have been Pfizer and GlaxoSmithKline (GSK).
Coronavirus bottleneck leaves 2m waiting for cancer care pharmatimes
June 04, 2020
Around 2.4 million people in the UK are currently waiting for cancer screening, tests or cancer treatment, a new analysis by Cancer Research UK has found.
First patient dosed in bemcentinib COVID-19 trial pharmatimes
June 04, 2020
Dosing has commenced in the UK Government-backed Phase II clinical trial assessing BerGenBio's bemcentinib in hospitalised COVID-19 patients.
Bayer to support Harvard Research Study to Evaluate Trust in Science, Including in COVID-19 pandemic worldpharmanews
June 04, 2020
With the public debate on the merits of scientific data throughout the COVID-19 pandemic, Bayer announced its support for a new, multi-year Harvard Data Science Initiative (HDSI) research effort.
COVID-19 drug development could benefit from approach used against flu worldpharmanews
June 04, 2020
A new study from researchers at The University of Texas at Austin has found that some antivirals are useful for more than helping sick people get better.
First do no harm - researchers urge halt in prescribing hydroxycholoroquine for COVID-19 worldpharmanews
June 04, 2020
The sacred oath taken by physicians during graduation from medical school to "First do no harm," the first words of the Hippocratic Oath, provides a strong impetus for a commentary just published in The American Journal of Medicine.